ArticleOrphanet journal of rare diseases2025
A de novo SALL4 mutation causes unilateral renal agenesis by misregulating genes involved in kidney development.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSALL4 is a transcription factor that plays a crucial role in early embryonic development and organogenesis, particularly in kidney development, although its specific regulatory mechanisms remain unclear.
methodsWe performed whole-exome sequencing (WES) to identify pathogenic variants in a fetus with unilateral renal agenesis and confirmed a variant in SALL4 using Sanger sequencing. The expression of wild-type or mutant SALL4 proteins in cells was used to determine whether the level and localization of the proteins were altered by the SALL4 variant. RNA sequencing was used to identify differentially expressed genes at the transcriptome level due to the SALL4 mutant protein. Finally, key differentially expressed proteins were verified using quantitative PCR and western blotting.
resultsA novel truncating mutation in SALL4 was identified through WES in a fetus with unilateral renal agenesis. Expression of the truncated SALL4 protein in cells revealed its predominant cytoplasmic localization, unlike the wild-type SALL4 protein, which was localized to the nucleus. Further RNA sequencing analysis indicated that the mutant SALL4 protein lost its transcriptional activation ability, with 1047 genes markedly downregulated compared to cells expressing wild-type SALL4. These downregulated genes were primarily enriched in biological processes such as cell activation, salt transmembrane transporter activity, and calcium ion binding. Additionally, we found that these differentially expressed genes mainly regulated fetal ureteric bud cells, suggesting that SALL4 mutations may ultimately lead to unilateral renal agenesis by affecting the development and function of fetal ureteric bud cells. Among these genes, two proteins crucial for kidney development, WNT11 and PAX2, were significantly downregulated in cells expressing the truncated SALL4 protein, suggesting that WNT11 and PAX2 may mediate the regulatory role of SALL4 in kidney development.
conclusionThis study elucidated the molecular mechanism by which SALL4 mutations lead to renal agenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.